HIV integrase inhibitors
US7897593B2 · kind B2 · utility
2Cited by
7References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 29, 2007 |
| Grant date | Mar 1, 2011 |
| Priority date | — |
| Expiry date | Dec 21, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D498/18
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The invention encompasses series bicyclic pyrimidinone compounds of Formula I which inhibit HIV integrase and prevent viral integration into human DNA. This action makes the compounds useful for treating HIV infection and AIDS. The invention also encompasses pharmaceutical compositions and methods for treating those infected with HIV.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.